Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Antiparkinson Agents (toxicity) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity) < Antiparkinson agent  Facettes :

List of bibliographic references indexed by Antiparkinson Agents (toxicity)

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000159 (2016) Matthieu F. Bastide [France] ; Simone Bido [France] ; Nathalie Duteil [France] ; Erwan Bézard [France]Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia.
000573 (2015) H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis]NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
000627 (2015) Fanny Charbonnier-Beaupel [France] ; Marion Malerbi [France] ; Cristina Alcacer [France] ; Khadija Tahiri [France] ; Wassila Carpentier [France] ; Chuansong Wang [États-Unis] ; Matthew During [États-Unis] ; Desheng Xu ; Paul F. Worley ; Jean-Antoine Girault [France] ; Denis Hervé [France] ; Jean-Christophe Corvol [France]Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia.
000A64 (2014) Mathieu Bourdenx [France] ; Anna Nilsson [Suède] ; Henrik Wadensten [Suède] ; Maria F Lth [Suède] ; Qin Li [République populaire de Chine] ; Alan R. Crossman [Royaume-Uni] ; Per E. Andrén [Suède] ; Erwan Bezard [République populaire de Chine]Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia.
001606 (2011) Sylvia Navailles [France] ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreChronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
001F30 (2009) Christelle Monville [France] ; Eduardo M. Torres ; Vladimir Pekarik ; Emma L. Lane ; Stephen B. DunnettGenetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model.
003087 (2003) Erwan Bézard [France] ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre SokoloffAttenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.
004089 (1998) Cristina Murer [France] ; Gustavo Dziewczapolski [Argentine] ; Liliana B. Menalled [Argentine] ; M. Carmen García [Argentine] ; Yves Agid [France] ; Oscar Gershanik [Argentine] ; Rita Raisman-Vozari [France]Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (toxicity)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents (toxicity)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (toxicity)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024